Abemaciclib in combination with endocrine therapy for East Asian patients with HR+, HER2− advanced breast cancer: MONARCH 2 & 3 trials

Masakazu Toi*, Kenichi Inoue, Norikazu Masuda, Hiroji Iwata, Joohyuk Sohn, In Hae Park, Seock Ah Im, Shin Cheh Chen, Sotaro Enatsu, P. Kellie Turner, Valérie A.M. André, Molly C. Hardebeck, Sachi Sakaguchi, Matthew P. Goetz, George W. Sledge

*Corresponding author for this work

Research output: Contribution to journal › Journal Article › peer-review

16 Scopus citations

Fingerprint

Dive into the research topics of 'Abemaciclib in combination with endocrine therapy for East Asian patients with HR+, HER2− advanced breast cancer: MONARCH 2 & 3 trials'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science